Thank you, Madam Chair, and my thanks to all of you for the comments here today. Shannon, welcome back. I know you've been our most avid participant at the back of the room during these hearings.
I have a few questions. With respect to Alzheimer's research, Canada is engaged in partnerships with the U.K., Germany, and France, and we are looking at potential partnerships in China and the U.S. What evidence of that are you seeing...? Is there any reason for optimism with these types of partnerships? Do you see any practical benefits for these collective working arrangements with other countries?